Regulation of TGF-β Family Signaling by Inhibitory Smads
Open accessThe DOI matches its Crossref record; 210 of the 211 references it cites were found in a registry or an index.
Abstract
Inhibitory Smads (I-Smads) have conserved carboxy-terminal MH2 domains but highly divergent amino-terminal regions when compared with receptor-regulated Smads (R-Smads) and common-partner Smads (co-Smads). Smad6 preferentially inhibits Smad signaling initiated by the bone morphogenetic protein (BMP) type I receptors ALK-3 and ALK-6, whereas Smad7 inhibits both transforming growth factor β (TGF-β)- and BMP-induced Smad signaling. I-Smads also regulate some non-Smad signaling pathways. Here, we discuss the vertebrate I-Smads, their roles as inhibitors of Smad activation and regulators of receptor stability, as scaffolds for non-Smad signaling, and their possible roles in the nucleus. We also discuss the posttranslational modification of I-Smads, including phosphorylation, ubiquitylation, acetylation, and methylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RAB11 285, which is responsible for endosomal recycling of TGFβ receptors 286, is recruited to the cilium in a process that is mediated by the subdistal appendage protein, CEP128 287. Consequently, loss of CEP128 leads to impaired phosphorylation of R-SMADs, which in zebrafish is associated with defective organ development 287.”
From Cellular signalling by primary cilia in development, organ function and disease (2019) · cites this paper as [287]
In the citing paper
“Also, non-mutational mechanisms impair the growth inhibitory response to TGF-β. In advanced tumors, TGFBR2 or SMAD2 genes are frequently silenced by histone and DNA methylation122,123. Additionally, increased inhibitory Smad6 or Smad7 expression in various carcinomas, including PDAC, attenuates Smad signaling124,125, whereas increased expression of the Smad corepressors c-Ski or SnoN, observed in”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [124]
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857 · cited 1×
“TGF-b family ligands trigger signaling through hetero-oligomerization of two types of transmembrane receptors with intrinsic serine-threonine kinase activities: the type I and type II receptors (Shi and Massagué 2003).”
BackgroundIdentification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundNon-Smad pathways in TGF-β signaling
Zhang, Y. E. (2009) · Cell Research · doi:10.1038/cr.2008.328 · Cited by 1,749 · cited 1×
“…# 2017 Cold Spring Harbor Laboratory Press; all rights reserved; doi: 10.1101/cshperspect.a022095 Cite this article as Cold Spring Harb Perspect Biol 2017;9:a022095 1 tivated receptors can transmit signals independent of Smad proteins (non-Smad signaling pathways) (Zhang 2009).”
BackgroundInfluentialIdentification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., & Matsumoto, K. (1995) · Science · doi:10.1126/science.270.5244.2008 · Cited by 1,343 · cited 1×
“TAK1 is a MAPKKK activated in response to TGF-b, interleukin-1, and several other inducers (Yamaguchi et al. 1995; Ninomiya-Tsuji et al. 1999; Shim et al. 2005).”
BackgroundHayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y.-Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Wrana, J. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80303-7 · Cited by 1,334 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundSMAD proteins control DROSHA-mediated microRNA maturation
Davis, B. N., Hilyard, A. C., Lagna, G., & Hata, A. (2008) · Nature · doi:10.1038/nature07086 · Cited by 1,244 · cited 1×
“Activated Smad proteins promote the maturation of miR-21 independent of Smad4 by associating with the stem region of pri-miR-21 (Davis et al. 2008).”
BackgroundSmad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation
Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H., & Wrana, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00134-9 · Cited by 1,205 · cited 1×
“2A) (Kavsak et al. 2000; Ebisawa et al. 2001; Murakami et al. 2003).”
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182 · cited 1×
“TAK1 is a MAPKKK activated in response to TGF-b, interleukin-1, and several other inducers (Yamaguchi et al. 1995; Ninomiya-Tsuji et al. 1999; Shim et al. 2005).”
BackgroundFantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5149 · Cited by 1,135 · cited 1×
“3), leading to enhanced TGF-b signaling and acquisition of regulatory properties by these cells, including an antiproliferative effect on CD4þ T cells (Fantini et al. 2004).”
BackgroundSmad6 inhibits signalling by the TGF-β superfamily
Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J.-I., Kawabata, M., & Miyazono, K. (1997) · Nature · doi:10.1038/39355 · Cited by 1,029 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundSelf-citation
Research works printed but not linked: 1
- 10.1172/jci200112367 · doi:10.1172/jci200112367 · Paper page
Cited by
Items 301–400 of 463
Sui, L., Xie, X., Fu, P., Du, J., & Peng, C. Y. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5391 · Cited by 13
“Smad proteins are phosphorylated by TGF‐β1 receptors, which relays the TGF‐β1 signal into the nucleus (57,58).”
BackgroundWei, T., Richter, G. T., Zhang, H., Sun, R. W., Smith, C. H., & Strub, G. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-21217-0 · Cited by 11
Sotiropoulos, M. G., & Chitnis, T. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577358 · Cited by 11
TGF-β-mediated suppression of NK cell function and targeting strategies in tumor immunotherapy
Wang, B., & Bi, J. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105141 · Cited by 10
DNA Conserved in Diverse Animals Since the Precambrian Controls Genes for Embryonic Development
Frith, M. C., & Ni, S. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad275 · Cited by 9
“Ptch genes encode the main receptors that recognize hedgehog signaling molecules, and Smad6 proteins inhibit response to BMP signaling molecules (Miyazawa and Miyazono 2017).”
BackgroundTargeting Smad-Mediated TGFß Pathway in Coronary Artery Bypass Graft
Ungogo, M. A. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420951037 · Cited by 10
“I-Smads downregulate TGFb receptors and the interaction of R-Smads and Co-Smad, with Smad6 specifically inhibiting BMP-induced signaling, whereas Smad7 inhibits signaling initiated by both TGFb and BMP.(72) Smad ubiquitin regulatory factors (Smurfs), type E3 ligases homologous to the E6accessory protein (HECT), intera…”
BackgroundLin, H., Dong, B., Qi, L., Wei, Y.-X., Zhang, Y., Cai, X., Zhang, Q., Li, J., & Li, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-4282 · Cited by 10
Novel Pharmacological Targets for Pulmonary Arterial Hypertension
Klinger, J. R. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200015 · Cited by 10
Zheng, M., Yang, Z., Shi, L., Zhao, L., Liu, K., & Tang, N. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101509 · Cited by 13
Cbfβ: A key regulator in skeletal stem cell differentiation, bone development, and disease
Zheng, C., Zhang, C., He, Y., Lin, S., Zhu, Z., Wang, H., & Chen, G. (2025) · The FASEB Journal · doi:10.1096/fj.202500030r · Cited by 9
Ling, R., Yin, X., Ma, L., Zhang, Y., Ma, Y., Gao, R., Geng, Y., Mu, X., Chen, X., Li, F., et al. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.139377 · Cited by 9
Lv, Y., Jin, Y., Zhou, Z., Liao, J.-B., Zhang, Z.-Q., Tang, L.-Y., Xie, X., Wang, S., Jin, M.-X., & Liu, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1725349 · Cited by 9
EphB2 Receptor Promotes Dermal Fibrosis in Systemic Sclerosis
Egal, É. S. A., Kamdem, S. D., Yoshigi, M., Yang, C., Pellizzari, S., Kameni, E. M., Helms, M. N., Assassi, S., Henkemeyer, M. J., Frech, T., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.42858 · Cited by 9
“48 Based on our RNA sequencing data set, we discovered gene enrichment of negative regulators of the TGF β /Smad signaling 36 in TGF-β – stimulated NHDFs with siRNA-mediated knockdown of EPHB2 (as compared with nontargeting TGF-β – stimulated dermal fi bro-blasts).”
Ungefroren, H., Kumarasinghe, A., Musfeldt, M., Fiedler, C., Lehnert, H., & Marquardt, J.-U. (2020) · Cancers · doi:10.3390/cancers12061545 · Cited by 9
“Whereas SMAD6 preferentially inhibits SMAD signaling initiated by the bone morphogenetic protein (BMP) type I receptors, SMAD7 interferes with both TGF β and BMP-induced Smad signaling [12] through multiple mechanisms in the cytoplasm and in the nucleus.”
Perception of breast cancer risk factors: Dysregulation of TGF-β/miRNA axis in Pakistani females
Ahmed, F., Adnan, M., Malik, A. M., Tariq, S., Kamal, F., & Ijaz, B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255243 · Cited by 8
“The signaling of TGF-β1 is controlled by the negative feedback mechanism that involves I-Smads (SMAD6 and SMAD7) [26].”
BackgroundInfluentialLi, Z., Zhao, J., Wu, Y., Fan, S., Yuan, H., Xia, J., Hu, L., Yang, H. J., Liu, J., Wu, X., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202302307r · Cited by 8
“29 Whether TRAF2 could influence the function of AXIN1 by catalyzing its ubiquitination remains unknown.”
BackgroundHBO1 determines SMAD action in pluripotency and mesendoderm specification
Zhang, C., Shan, Y., Lin, H., Zhang, Y., Qi, X., Zhu, J., Zhou, T., Lin, A., Chen, Q., Wang, J., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae158 · Cited by 8
Li, Y., Jiang, Y., Yan, H., Qin, Z., Peng, Y., Lv, D., & Zhang, H. (2024) · iScience · doi:10.1016/j.isci.2024.110775 · Cited by 8
Huang, W., Zhang, Z., Li, X., Zheng, Q., Wu, C., Liu, L., Chen, Y., Zhang, J., & Jiang, X. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00925-5 · Cited by 8
EPRS1 Controls the TGF-β Signaling Pathway via Interaction with TβRI in Hepatic Stellate Cell
Yoon, I., Song, J. A., Suh, J. H., Kim, S., Son, J., Kim, J. H., Jang, S. Y., Hwang, K. Y., Kim, M. H., & Kim, S. (2023) · Molecular and Cellular Biology · doi:10.1080/10985549.2023.2205344 · Cited by 8
Liu, Q., Zhao, R., Wang, D., Li, P., Qu, Y., & Ji, X. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128127 · Cited by 8
Zhong, Z., Wu, T., Zhu, T., Pang, Y., Li, Q., & Su, P. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.06.004 · Cited by 8
MEK 1 inhibition and bleeding in hereditary haemorrhagic telangiectasia
Shovlin, C. L., Patel, D., Bielowka, A. M., Ledermann, J. A., Modarresi, A., Bernabeu-Herrero, M. E., Aldred, M. A., & Alsafi, A. (2023) · British Journal of Haematology · doi:10.1111/bjh.19167 · Cited by 8
Cellular Compartmentalization as a Physical Regulatory Mechanism of Signaling Pathways
Fayad, A. N., Mazo-Durán, D., & Míguez, D. G. (2024) · Biophysica · doi:10.3390/biophysica4040042 · Cited by 7
Long, M., Sun, J., Zhou, D., Chen, C., Shu, J., Mao, X., Yu, K., Liang, M., Chen, L., Wang, Y., et al. (2025) · Small · doi:10.1002/smll.202501610 · Cited by 7
METTL3 Modulates Radiation‐Induced Cardiac Fibrosis via the Akt/ mTOR Pathway
Qiao, S., Tang, C., Zhu, J., Feng, Y. Y., Li, X., Zhu, J., & Gu, X. (2025) · The FASEB Journal · doi:10.1096/fj.202403143rrrr · Cited by 7
“Inhibition of Akt significantly attenuated pressure- overload-induced cardiac fibrosis [31].”
Kwon, M.-J., Kim, J. H., Lee, J., Ko, E.-J., Park, H.-W., Shin, J., Ahn, E., & Kim, N. K. (2022) · Biomedicines · doi:10.3390/biomedicines10071481 · Cited by 7
“Runt-related transcription factors (RUNXs) are also involved in the TGF-β signaling pathway, working synergistically with SMADs [12,13].”
BackgroundGu, W., Lei, J., Zhu, H., Xiao, Y., Zhang, Z., & Zhao, L. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07764-9 · Cited by 7
“BMP ligand signals are transmitted downstream by phosphorylating R-Smads, including Smad2 and Smad3, and are involved in modulating gene expression in the nucleus [13, 14].”
BackgroundGastrointestinal pharmacology activins in liver health and disease
Hamang, M., Yaden, B. C., & Dai, G. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115668 · Cited by 7
Inhibition of FGF and TGF-β Pathways in hESCs Identify STOX2 as a Novel SMAD2/4 Cofactor
Renz, P. F., Spies, D., Tsikrika, P., Wutz, A., Beyer, T. A., & Ciaudo, C. (2020) · Biology · doi:10.3390/biology9120470 · Cited by 7
“Upon SB treatment, SMAD7 is depleted and cannot longer inhibit TGF-β [39] or epithelial–mesenchymal transition (EMT) [40], leading to the upregulation of both EMT actor SERPINE1 [41] and EMT suppressor HMOX1 [42].”
BackgroundWu, Z., Li, Y., Niu, Y., Lu, J., Yan, Z., Xu, T., Guo, Y., Dong, Z., & Guo, W. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23350 · Cited by 7
“SMAD family member 7 (SMAD7), as an inhibitory I‐SMAD, is one of the major undertakers of regulating the signal transduction of TGF‐β family cytokines.(19) It can form stable complexes with activated TGF‐β type I receptors and thereby blocking the phosphorylation of R‐ Smads, or recruit ubiquitin E3 ligases to cause t…”
BackgroundPeng, Y., Lei, H., Zhao, J., Wang, H., Luo, Z., Wang, D., Shi, S., Wang, T., Li, J., Pang, Z., et al. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.123784 · Cited by 7
“This mechanism resembles the decoy receptor strategy but operates with endogenous precision, avoiding the off-target effects commonly associated with global TGF-β pathway inhibition [14, 37].”
Chen, K., Wang, J., Liu, Q., Wang, H., Ning, X., Wang, J., Hu, X., Zong, L., Wu, L., Luo, T., et al. (2026) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2026.125123 · Cited by 8
Stem cell genes in atheromatosis: The role of Klotho, HIF1α, OCT4, and BMP4
Mylonas, K. S., Karangelis, D., Androutsopoulou, V. A., Chalikias, G., Tziakas, D. N., Mikroulis, D. A., Iliopoulos, D., Nikiteas, N. I., & Schizas, D. (2022) · IUBMB Life · doi:10.1002/iub.2667 · Cited by 6
“For example, inhibitory SMADs can recruit SMURF1 and SMURF2 as well as E3 ubiquitin ligases to degrade activated receptors.(45) In addition, BMP signaling is regulated by different types of co-receptors (type III receptors) such as betaglycan and endoglin (which is highly expressed in cardiovascular tissues).”
BackgroundHu, J., Jiang, J., Xu, B., Li, Y., Wang, B., He, S., Ren, X., Shi, B., Zhang, X., Zheng, H., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117590 · Cited by 6
Xu, H., Akhmet, N., Luo, Y., Zhenggang, G., Pan, C., Song, E., Malmakov, N., Akhatayeva, Z., & Lan, X. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1280548 · Cited by 6
Estienne, A., Jarrier-Gaillard, P., Staub, C., Venturi, É., Vern, Y. L., di Clemente, N., Monniaux, D., & Monget, P. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa077 · Cited by 6
Chen, Q., Yi, J., Liu, F., Li, J., Lu, K., Wang, X., Zhang, F., Li, Y., Wu, L., Yang, X., et al. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.10.014 · Cited by 6
Uptegrove, A., Chen, C., Sahagun-Bisson, M., Kulkarni, A. K., Louie, K. W., Ueharu, H., Mishina, Y. M., & Omi, M. (2024) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2024.106096 · Cited by 5
“Subsequently, these activated Smads form complexes with Smad4, resulting in nuclear translocation and consequent modulation of gene expression (Heldin & Moustakas, 2012; Miyazawa & Miyazono, 2017).”
Jiang, F., Tang, J., Wei, X., Pan, H., Fan, X., Zhang, P., & Guo, S. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01062-9 · Cited by 5
Sangboonruang, S., Semakul, N., Poomanee, W., Thavanapong, T., Roytrakul, S., Charoenlappanit, S., Thaisakun, S., Khantipongse, J., Netirat, N., Tongsong, A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-04673-2 · Cited by 5
Ling, J., Zhang, J., Wang, B., FengSong, J., Li, T., & Chen, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02337-2 · Cited by 5
He, R., Xiao, C., Lei, W., Chen, G., Li, Y., & Luo, O. J. (2025) · BMC Biology · doi:10.1186/s12915-025-02484-5 · Cited by 5
Ma, T., Hao, H., Wang, S., Qiu, D., Cao, W., Deng, W., Wang, S., Li, X., Zhang, Z., Wei, X., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1795174 · Cited by 11
“IFN-γ binding to its receptor activates the downstream Janus Kinase (JAK)-STAT pathway, resulting in the phosphorylation of STAT1 (p-STAT1) (Miyazawa and Miyazono, 2017).”
Pellino Proteins in Viral Immunity and Pathogenesis
Jensen, L. E. (2023) · Viruses · doi:10.3390/v15071422 · Cited by 5
Enhanced BMP signaling in Cathepsin K-positive tendon progenitors induces heterotopic ossification
Yamaguchi, H., Li, M., Kitami, M., Swaminathan, S., Mishina, Y. M., & Komatsu, Y. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149147 · Cited by 5
Asoka, A. S., Kolikkandy, A., Nair, B., Kamath, A. J., Sethi, G., & Nath, L. R. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300793 · Cited by 8
A chronic signaling TGFb zebrafish reporter identifies immune response in melanoma
Noonan, H. R., Thornock, A., Barbano, J., Xifaras, M. E., Baron, C. S., Yang, S. P., Koczirka, K., McConnell, A. M., & Zon, L. I. (2024) · eLife · doi:10.7554/elife.83527 · Cited by 5
“…are thought to circumvent the tumor suppressive effects of TGFb via mutations or epigenetic modifications ( Derynck et al., 2021 ; Kim et al., 2021 ; Massagué et al., 2000 ; Zhang et al., 2017 ; Seoane and Gomis, 2017 ; Suriyamurthy et al., 2019 ; Miyazawa and Miyazono, 2017 ; Tang et al., 2018 ).”
BackgroundHarnessing the power of miRNAs for precision diagnosis and treatment of male infertility
Doghish, A. S., Elsakka, E. G. E., Moustafa, H. A. M., Ashraf, A., Mageed, S. S. A., Mohammed, O. A., Abdel‐Reheim, M. A., Zaki, M. B., Elimam, H., Rizk, N. I., et al. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03594-7 · Cited by 5
“In cooperation with other cofactors, after translocating into the nucleus, the SMAD2/3/4 complex controls the target genes’ transcription (Hata and Chen 2016; Miyazawa and Miyazono 2017; Deng et al. 2019).”
TBX1 regulates myogenic differentiation by activating the TGFβ-Smad2/3 pathway in myoblasts
Cen, H., Luo, H., Luo, B., Pin, F., Zhang, Y., & Zhang, Y. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221112087 · Cited by 5
van Ravensteijn, S. G., Amir, A. L., Tauriello, D. V. F., van Herpen, C. M. L., Boers‐Sonderen, M. J., Wesseling-Rozendaal, Y. J. W., van Brussel, A., Keizer, D. M., Verheul, H. M. W., & Bol, K. F. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae108 · Cited by 5
“SMAD7 interacts with TGF-β R1 and interferes with the activation of SMAD2 and SMAD3, functioning as a negative feedback loop to prevent continuous activation [15, 16].”
Su, C., Tao, D., Ren, L., Guo, S., Zhou, W., Wu, H., & Jiang, H. (2020) · Tissue and Cell · doi:10.1016/j.tice.2020.101406 · Cited by 5
Tarlton, J., Lightbody, R. J., Patterson, S., & Graham, A. (2021) · Biology · doi:10.3390/biology10030218 · Cited by 6
“Repression of SMAD7 has not previously been reported after HDL treatment, but this protein is a wellestablished inhibitor of the TGFβ signalling pathway which regulates fibrosis, inflammation and wound healing and cancer, and loss of Smad7 in mice is associated with enhanced cell proliferation and reduced apoptosis [6…”
BackgroundAugustine, D., Lakshminarayana, S., Nadeem, A. M., Nagaraj, B., Jagadish, D. A., & Shetty, D. (2021) · The Journal of Contemporary Dental Practice · doi:10.5005/jp-journals-10024-3122 · Cited by 5
Fard, A. H. H., Valizadeh, M., Mazaheri, Z., & Hosseini, J. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00884-4 · Cited by 5
Carroll, M., Alliston, T. N., & Dole, N. S. (2023) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00802-w · Cited by 5
Kraus, L., Fredericks, S., & Scheeler, K. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1539826 · Cited by 4
Sciriha, G. G., Borg, J., Sultana, J., & Borg, J. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11191-3 · Cited by 4
“It has been shown to preferentially inhibit BMP-induced SMAD signaling (Miyazawa and Miyazono 2017).”
Rahayu, I., Arfian, N., Timotius, K. H., & Wahyuningsih, M. S. H. (2024) · PubMed Central · doi:10.22088/ijmcm.bums.13.3.234 · Cited by 4
Elgabry, R. M., Fawzy, G. A., Meselhy, K. M., Ramadan, N. M., Younes, N. F., Al‐Taweel, A. M., Perveen, S., & Sedeek, M. S. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00762-1 · Cited by 4
“SMAD3 serves as the principal subcellular signaling molecule in the TGF-β signaling pathway, which phosphorylation controls the transcription of extracellular matrix proteins [46].”
Natural products targeting ubiquitination to combat kidney fibrosis
Li, L., Huang, X., Chen, Y., Liu, J., Qiao, Y., Fan, W., Zhang, P., Yan, X., & Chen, M. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00757-4 · Cited by 4
Zheng, H. W., Huang, N., Lin, J., Yan, L., Jiang, Q.-G., & Yang, W.-Z. (2023) · Advances in Medical Sciences · doi:10.1016/j.advms.2022.12.001 · Cited by 4
Deamidation enables pathogenic SMAD6 variants to activate the BMP signaling pathway
Li, L., Lü, L., Xiao, Z., Lv, J., Huang, H., Wu, B., Zhao, T., Li, C., Wang, W., & Wang, H. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2532-5 · Cited by 5
“The conserved SMAD6 MH2 domain is required for interactions with other proteins, including activated BMP receptors and phosphorylated SMAD1/5/8, to inhibit the BMP signaling pathway (Miyazawa and Miyazono, 2017).”
Chen, Y., Liu, X., Liu, X., Cui, L., He, Z., Gao, Z., Liu, L., Li, Z., Wan, Z., & Yu, Z. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211012288 · Cited by 4
New Insights into Cancer Targeted Therapy: Nodal and Cripto-1 as Attractive Candidates
Arboretto, P., Cillo, M., & Leonardi, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157838 · Cited by 5
“This signal cascade is tightly regulated also by Inhibitory SMADs (I-SMADS) that counteract the effect of R-SMAD antagonizing TGF-β signaling [11].”
BackgroundHuang, W., Wu, Y., Zhao, Y., Gan, X., Zhang, B., Cen, X. B., Huang, X., & Zhao, Z. (2022) · Oral Diseases · doi:10.1111/odi.14351 · Cited by 6
YWK-II/APLP2 inhibits TGF-β signaling by interfering with the TGFBR2–Hsp90 interaction
Tuersuntuoheti, A., Li, Q., Yu, T., Li, X., Huang, R. S., Lü, Y., Li, K., Liang, J., Miao, S., Wu, W., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119548 · Cited by 4
Enhanced BMP signaling leads to enlarged nasal cartilage formation in mice
Yamaguchi, H., Swaminathan, S., Mishina, Y. M., & Komatsu, Y. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.08.053 · Cited by 4
The mechanism of patchouli alcohol in treating IBS-D based on BMP-Smad pathway
Lu, Y.-L., Huang, C., Huang, S.-Y., Li, T., Wy, C., Yi, S.-L., Pei, Y., Lu, J.-T., Chen, Z.-Y., Cao, H., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118050 · Cited by 3
Cuesta-López, L., de la Rosa, I. A., Pérez‐Sánchez, C., Betancourt, A. B., Ruiz-Ponce, M., Barranco, A. M., Ortiz-Buitrago, P., Ladehesa-Pineda, L., Puche-Larrubia, M. Á., Martin-Salazar, E., et al. (2026) · RMD Open · doi:10.1136/rmdopen-2025-006136 · Cited by 3
Genes involved in chronic wound healing and their therapeutic potential
Karikalan, B., & Chakravarthi, S. (2023) · IP Archives of Cytology and Histopathology Research · doi:10.18231/j.achr.2023.020 · Cited by 3
Wang, M., Zhu, Y., Zhao, H., & Zhao, H. (2023) · PubMed Central · doi:10.19852/j.cnki.jtcm.20230802.005 · Cited by 6
Unveiling the role of Pafah1b3 in liver fibrosis: A novel mechanism revealed
Lin, L., Yang, S., Li, X., Zhang, W., & Zheng, J. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101158 · Cited by 3
Xu, J., Shi, P., Yang, L., & Cui, H. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.04.042 · Cited by 3
Najafi, S., Barasa, L., Frianela, J. M. J., Alkhamisy, J. H., Yoganathan, S., & Perron, J. C. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2810268 · Cited by 3
Fung, M. V., Armstrong, J. J., Zhang, R., Vinokurtseva, A., Liu, H., & Hutnik, C. M. L. (2024) · Bioengineering · doi:10.3390/bioengineering11020142 · Cited by 3
“Inhibition of YAP/TAZ augments inhibitory SMAD7 activity levels and prevents the SMAD2/3 complex from translocating into the nucleus to induce transcription of myofibroblast-related genes [46,47].”
BackgroundTSPYL1 as a Critical Regulator of TGFβ Signaling through Repression of TGFBR1 and TSPYL2
Tan, H., Miao, M. X., Luo, R. X., So, J., Peng, L., Zhu, X., Leung, E. H. W., Zhu, L., Chan, K. M., Cheung, M. C. H., et al. (2024) · Advanced Science · doi:10.1002/advs.202306486 · Cited by 3
The ciliary protein C2cd3 is required for mandibular musculoskeletal tissue patterning
Brooks, E. C., Han, S. J. Y., Paese, C. L. B., Lewis, A. A., Aarnio, M., & Brugmann, S. A. (2024) · Differentiation · doi:10.1016/j.diff.2024.100782 · Cited by 2
Rana-Seyfert, D., Grab, A. L., & Breitkopf‐Heinlein, K. (2025) · Bioscience Reports · doi:10.1042/bsr20253294 · Cited by 2
“One study reported that the MH2 domain (amino acids 332–496) of Smad6 binds directly to Smad4 [75] and thereby the Smad1/5/8-Smad4 complex that is required to transmit BMP-9 signals to the nucleus cannot form [68,76].”
InfluentialFrisch, A., Wilkinson, J. D., & NYQUIST, A. S. (2026) · AME Case Reports · doi:10.21037/acr-2025-135 · Cited by 2
“Ligand activation of the transmembrane TGF-β receptors triggers a phosphorylation cascade leading to downstream activation of the SMAD pathway (7).”
Cordeiro, M. C., Barbero, A., Martín, I., & Stoddart, M. J. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01247-w · Cited by 2
Mohammed, Y. T., Mohammed, N. H., & Arif, I. S. (2023) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v23i4.1098 · Cited by 2
He, Q., Lai, Z., Zhai, Z., Zou, B., Shi, Y., & Feng, C. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1501735 · Cited by 3
Sun, Y., & Li, Z. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00741-1 · Cited by 2
SMAD4 mutations identified in Iranian patients with colorectal cancer and polyp.
Sadeghi, R. N., Saeedi, N., Sahba, N., & Sadeghi, A. (2021) · Gastroenterology and hepatology from bed to bench. · Cited by 3
Miller, D. S. J., & Hill, C. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00242-x · Cited by 3
Lee, J. M., Yon, D. K., Kim, S. S., & Yeo, S. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052291 · Cited by 1
“SMAD6 inhibits the phosphorylation and activation of receptor-regulated SMADs, modulating both BMP and TGF-β signaling pathways [33].”
Prasad, M., Marimuthu, K. A., & ShanmugaSundaram, K. (2025) · Texila international journal of public health · doi:10.21522/tijph.2013.13.02.art004 · Cited by 1
Lalman, C., Stabler, K. R., Disatham, J., Brennan, L., Kantorow, M., & Walker, J. L. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110628 · Cited by 1
“This early surge supports a pro-regenerative program that counters TGF-β mediated fibrotic signaling and promotes epithelial maintenance and repair (Miyazawa and Miyazono, 2017; Perez-Shibayama et al., 2024).”
Kawczak, P., Feszak, I. J., & Bączek, T. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196853 · Cited by 1
“Epi-genetic modifiers [60], microRNAs [61], long non-coding RNAs [62], and tumor microenvironment (TME) components [63] also influence EMP-driven metastasis and therapeutic response.”
Sun, H., Wang, X., Zhu, L.-L., Shahbaz, G., Gu, R., Huang, Q., Li, W., & Xing, F. (2025) · Animals · doi:10.3390/ani15223271 · Cited by 1
“As an I-Smad, SMAD7 antagonizes TGF-β /BMP signaling by competing for receptor binding and recruiting SMURF1/2 to promote R-Smad degradation, establishing a negative feedback loop [42].”
Advances in Stem Cell-Derived Organoids for Treating and Understanding Lung Diseases
Raut, N., Paliwal, H., Prajapati, B. G., Desai, S. A., & Patel, V. P. (2026) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00544-4 · Cited by 1
HDAC8 impairs tight junctions in allergic rhinitis through Smad7 deacetylation
Chang, H.-H., Cao, Z.-N., Dang, P.-H., Wei, M., Li, Y., Zhang, H.-P., & Wang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1793810 · Cited by 1
Takizawa, N., Hironaka, T., Watanabe, H., Suetsugu, H., YOSHIOKA, K., Horii, Y., Nagata, Y., Matoba, H., Kosako, H., Hamase, K., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci182216 · Cited by 1
“We therefore focused on SMAD3 phosphorylation, a key mediator of TGF-β signaling (40, 41).”
Transforming Growth Factor-β1 and Tumor Development
Dahl, L. (2023) · Science Insights · doi:10.15354/si.23.re298 · Cited by 1
Nuryana, C. T., Agustin, T. P., Haryana, S. M., Wirohadidjojo, Y. W., & Arfian, N. (2023) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v15i6.2580 · Cited by 3
“This study shows that AFM ameliorates UVB-induced fibroblast photoaging by upregulating TGF-β/Smad3 expressions and downregulating Smad7 expression.”
BackgroundWu, Z., Li, W., Zhu, H., Guo, S., Zhang, Y., Zhang, L., Guo, X., Cao, J., & Wang, Z. (2024) · Process Biochemistry · doi:10.1016/j.procbio.2024.01.006 · Cited by 1
“Through binding to the TGF-β receptor, TGF β -induced EMT could lead to the activation of both classical (SMADs) pathway and non-classical pathways (i.e. RhoA, JNK/p38, PI3K/Akt, and JNK/p38) 31 .”
BackgroundSong, S., & Song, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1629962 · Cited by 1
Early mechanisms of aortic failure in a zebrafish model for thoracic aortic dissection and rupturePreprint
Vanhooydonck, M., Verlee, M., Silva, M. S., Pottie, L., Boel, A., Impe, M. V., Saffel, H. D., Caboor, L., Tapaneeyaphan, P., Bonnin, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.12.580022 · Cited by 2
Azadi, A. S. (2018) · Figshare
Metadata
- Authors
- Miyazawa, K., & Miyazono, K.
- Affiliations
- University of Yamanashi (JP)
- The University of Tokyo (JP)
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-12-05
- Volume
- 9
- Issue
- 3
- Pages
- a022095
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC5334261
- OpenAlex
- W2560615789
- Cited by
- 439
- References
- 211
- Citations by year
- 2026: 25 · 2025: 32 · 2024: 43 · 2023: 56 · 2022: 61 · 2021: 78 · 2020: 56 · 2019: 33 · 2018: 32 · 2017: 19 · 2016: 2
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (15H05774)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Keywords
- inhibitory Smads, Smad6, Smad7, TGF-beta signaling, BMP signaling, Smad activation, receptor stability, non-Smad signaling, post-translational modification, phosphorylation, ubiquitination, acetylation, methylation
- MeSH terms
- Animals, Humans, Protein Conformation, Protein Processing, Post-Translational, Signal Transduction, Transforming Growth Factor beta, Smad Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.